Protein expression of CD44 in patients with meningioma tumors: association with clinicopathological parameters and survival
Our overall findings addressed that a study of CD44 protein expression would be beneficiated to meningioma patients from unnecessary overtreatment and drug-induced toxicity. Also, CD44 could be one of the promising biomarkers that might differentiate high-risk meningioma patients for better treatment management.
Authors
- Priti Trivedi (ORCID: https://orcid.org/0000-0003-1627-2345)
- Trupti Trivedi (ORCID: https://orcid.org/0000-0002-3685-6842)
- Neha Bhalala (ORCID: https://orcid.org/0000-0002-6930-7372)
- Kirti Dialani
Institutions
- Gujarat Cancer & Research Institute (IN)
Publication Details
- Journal
- Journal of the Egyptian National Cancer Institute
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1186/s43046-024-00249-9
- Citations
- 2
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Gujarat Cancer and Research Institute